184 related articles for article (PubMed ID: 20876802)
1. RasGRP3 contributes to formation and maintenance of the prostate cancer phenotype.
Yang D; Kedei N; Li L; Tao J; Velasquez JF; Michalowski AM; Tóth BI; Marincsák R; Varga A; Bíró T; Yuspa SH; Blumberg PM
Cancer Res; 2010 Oct; 70(20):7905-17. PubMed ID: 20876802
[TBL] [Abstract][Full Text] [Related]
2. Function of RasGRP3 in the formation and progression of human breast cancer.
Nagy Z; Kovács I; Török M; Tóth D; Vereb G; Buzás K; Juhász I; Blumberg PM; Bíró T; Czifra G
Mol Cancer; 2014 Apr; 13():96. PubMed ID: 24779681
[TBL] [Abstract][Full Text] [Related]
3. RasGRP3, a Ras activator, contributes to signaling and the tumorigenic phenotype in human melanoma.
Yang D; Tao J; Li L; Kedei N; Tóth ZE; Czap A; Velasquez JF; Mihova D; Michalowski AM; Yuspa SH; Blumberg PM
Oncogene; 2011 Nov; 30(45):4590-4600. PubMed ID: 21602881
[TBL] [Abstract][Full Text] [Related]
4. Upregulation of RASGRP3 expression in prostate cancer correlates with aggressive capabilities and predicts biochemical recurrence after radical prostatectomy.
Zeng X; Hu Z; Wang Z; Tao J; Lu T; Yang C; Lee B; Ye Z
Prostate Cancer Prostatic Dis; 2014 Jun; 17(2):119-25. PubMed ID: 24418912
[TBL] [Abstract][Full Text] [Related]
5. RasGRP3, a Ras guanyl releasing protein 3 that contributes to malignant proliferation and aggressiveness in human esophageal squamous cell carcinoma.
Zhang Z; Ma M; Hu R; Xu B; Zong L; Wei H; Meng Y
Clin Exp Pharmacol Physiol; 2018 Jul; 45(7):720-728. PubMed ID: 29461644
[TBL] [Abstract][Full Text] [Related]
6. RasGRP3 controls cell proliferation and migration in papillary thyroid cancer by regulating the Akt-MDM2 pathway.
Qiu W; Xia X; Qiu Z; Guo M; Yang Z
Gene; 2017 Oct; 633():35-41. PubMed ID: 28864115
[TBL] [Abstract][Full Text] [Related]
7. Integration of DAG signaling systems mediated by PKC-dependent phosphorylation of RasGRP3.
Teixeira C; Stang SL; Zheng Y; Beswick NS; Stone JC
Blood; 2003 Aug; 102(4):1414-20. PubMed ID: 12730099
[TBL] [Abstract][Full Text] [Related]
8. A vascular gene trap screen defines RasGRP3 as an angiogenesis-regulated gene required for the endothelial response to phorbol esters.
Roberts DM; Anderson AL; Hidaka M; Swetenburg RL; Patterson C; Stanford WL; Bautch VL
Mol Cell Biol; 2004 Dec; 24(24):10515-28. PubMed ID: 15572660
[TBL] [Abstract][Full Text] [Related]
9. Importance of the REM (Ras exchange) domain for membrane interactions by RasGRP3.
Czikora A; Kedei N; Kalish H; Blumberg PM
Biochim Biophys Acta Biomembr; 2017 Dec; 1859(12):2350-2360. PubMed ID: 28912101
[TBL] [Abstract][Full Text] [Related]
10. In vitro modulation of tumor progression-associated properties of hormone refractory prostate carcinoma cell lines by cytokines.
Sokoloff MH; Tso CL; Kaboo R; Taneja S; Pang S; deKernion JB; Belldegrun AS
Cancer; 1996 May; 77(9):1862-72. PubMed ID: 8646686
[TBL] [Abstract][Full Text] [Related]
11. Vav3 oncogene is overexpressed and regulates cell growth and androgen receptor activity in human prostate cancer.
Dong Z; Liu Y; Lu S; Wang A; Lee K; Wang LH; Revelo M; Lu S
Mol Endocrinol; 2006 Oct; 20(10):2315-25. PubMed ID: 16762975
[TBL] [Abstract][Full Text] [Related]
12. The Vav3 oncogene enhances the malignant potential of prostate cancer cells under chronic hypoxia.
Hirai K; Nomura T; Yamasaki M; Inoue T; Narimatsu T; Chisato Nakada PD; Yoshiyuki Tsukamoto PD; Matsuura K; Sato F; Moriyama M; Mimata H
Urol Oncol; 2014 Feb; 32(2):101-9. PubMed ID: 23403204
[TBL] [Abstract][Full Text] [Related]
13. Phorbol esters modulate the Ras exchange factor RasGRP3.
Lorenzo PS; Kung JW; Bottorff DA; Garfield SH; Stone JC; Blumberg PM
Cancer Res; 2001 Feb; 61(3):943-9. PubMed ID: 11221888
[TBL] [Abstract][Full Text] [Related]
14. Liprin-alpha2 gene, protein tyrosine phosphatase LAR interacting protein related gene, is downregulated by androgens in the human prostate cancer cell line LNCaP.
Fujinami K; Uemura H; Ishiguro H; Kubota Y
Int J Mol Med; 2002 Aug; 10(2):173-6. PubMed ID: 12119554
[TBL] [Abstract][Full Text] [Related]
15. Downregulation of androgen receptor expression by luteolin causes inhibition of cell proliferation and induction of apoptosis in human prostate cancer cells and xenografts.
Chiu FL; Lin JK
Prostate; 2008 Jan; 68(1):61-71. PubMed ID: 18008333
[TBL] [Abstract][Full Text] [Related]
16. S100A16 promotes cell proliferation and metastasis via AKT and ERK cell signaling pathways in human prostate cancer.
Zhu W; Xue Y; Liang C; Zhang R; Zhang Z; Li H; Su D; Liang X; Zhang Y; Huang Q; Liu M; Li L; Li D; Zhao AZ; Liu Y
Tumour Biol; 2016 Sep; 37(9):12241-12250. PubMed ID: 27240591
[TBL] [Abstract][Full Text] [Related]
17. 6-(3,4-Dihydro-1H-isoquinoline-2-yl)-N-(6-methoxypyridine-2-yl) nicotinamide-26 (DIMN-26) decreases cell proliferation by induction of apoptosis and downregulation of androgen receptor signaling in human prostate cancer cells.
Choi HE; Shin JS; Leem DG; Kim SD; Cho WJ; Lee KT
Chem Biol Interact; 2016 Dec; 260():196-207. PubMed ID: 27720946
[TBL] [Abstract][Full Text] [Related]
18. Establishment and characterization of androgen-independent human prostate cancer cell lines, LN-REC4 and LNCaP-SF, from LNCaP.
Iwasa Y; Mizokami A; Miwa S; Koshida K; Namiki M
Int J Urol; 2007 Mar; 14(3):233-9. PubMed ID: 17430262
[TBL] [Abstract][Full Text] [Related]
19. Androgen deprivation induces selective outgrowth of aggressive hormone-refractory prostate cancer clones expressing distinct cellular and molecular properties not present in parental androgen-dependent cancer cells.
Tso CL; McBride WH; Sun J; Patel B; Tsui KH; Paik SH; Gitlitz B; Caliliw R; van Ophoven A; Wu L; deKernion J; Belldegrun A
Cancer J; 2000; 6(4):220-33. PubMed ID: 11038142
[TBL] [Abstract][Full Text] [Related]
20. Phosphorylation of RasGRP3 on threonine 133 provides a mechanistic link between PKC and Ras signaling systems in B cells.
Zheng Y; Liu H; Coughlin J; Zheng J; Li L; Stone JC
Blood; 2005 May; 105(9):3648-54. PubMed ID: 15657177
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
